COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04/06/2026
CONSHOHOCKEN, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04/06/2026
SOUTH SAN FRANCISCO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
Nyxoah Announces Proposed Offering of Ordinary Shares
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – June 4, 2026, 10:02 pm CET / 4:02 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 4 juin 2026, 22h02 CET / 16h02 ET – Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Nyxoah Enters New Chapter of Long Term Value Creation
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Enters New Chapter of Long Term Value Creation Commencement of process to transition to a U.S.-based CEO Transition to support further acceleration of commercial Genio [...]
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme Lancement du processus de transition vers un Chief Executive Officer basé aux États-Unis Cette [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2026, the Company [...]
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
04/06/2026
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]
CooperCompanies Announces Second Quarter 2026 Results
04/06/2026
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026. Second [...]
London Specialist Dentists Announce the Use of Ozone Therapy in Periodontal Treatment and Dental Implants
04/06/2026
LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- London Specialist Dentists has announced the use of medical-grade Ozone Therapy as part of its advanced approach to periodontal treatment, dental implant care, and minimally [...]
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
04/06/2026
CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, [...]
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
04/06/2026
EAGLE, Idaho, June 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care, and senior living companies, and Hartford [...]
Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment
04/06/2026
The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery Elfrida, ARIZONA, June 04, 2026 (GLOBE NEWSWIRE [...]
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS
04/06/2026
CROSSJECT Société anonyme au capital social de 5 977 067,50 Euros Siège social : 6, rue Pauline Kergomard, ZAC Parc Mazen Sully, 21000 Dijon 438 822 215 R.C.S. Dijon DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS [...]
Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award
04/06/2026
Applied Behavior Analysis International Brain Injury Special Interest Group Honors Four-Decade Career in Neurorehabilitation at 52nd Annual Conference BAKERSFIELD, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Centre for [...]
MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection
04/06/2026
Technology powered by AI can Detect Cocaine, Cannabis, Psychedelics, Narcotic, Alcohol Use and Human Fatigue in Real-Time from Your Voice 15 World firsts claimed by the Company in patent applications filed Discoveries [...]
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
04/06/2026
Leadership appointments fortify Genovyn’s scientific, translational, and development capabilities across its AI-driven platform WILMINGTON, N.C., June 04, 2026 (GLOBE NEWSWIRE) -- GENOVYN, an AI-enabled biotechnology [...]
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
04/06/2026
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neurostimulation Patent [...]
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
04/06/2026
The landmark achievement reflects the collective impact of patients, donors, caregivers, researchers, volunteers, advocates, financial supporters and transplant partners advancing access to life-saving cell therapy [...]

Pages